Related Experiment Video

Updated: Feb 15, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.6K

miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS

Hao Zhang1, Qian-Yun He2, Guang-Chao Wang1

  • 1Department of Orthopedics Trauma, Changhai Hospital, Second Military Medical University, Shanghai, China.

Bioscience Reports
|January 24, 2018
PubMed

Insights

MicroRNA-422a (miR-422a) acts as a tumor suppressor in osteosarcoma by inhibiting cancer cell growth and promoting apoptosis. Restoring miR-422a shows therapeutic potential for osteosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Osteosarcoma is the most common primary bone cancer in children and adolescents.
  • The molecular mechanisms driving osteosarcoma development are not fully understood.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.

Purpose of the Study:

  • To investigate the role of miR-422a in osteosarcoma.
  • To explore the potential of miR-422a as a therapeutic target for osteosarcoma.

Main Methods:

  • Comparative analysis of miRNA expression in osteosarcoma tissues and normal adjacent tissues.
  • Investigation of epigenetic modifications (H3K9me3, H3K27me3, H3K4me3) on the miR-422a promoter.
  • In vitro and in vivo studies to assess the anti-tumor effects of miR-422a.
  • Identification of miR-422a target genes using molecular assays.

Main Results:

  • miR-422a expression was significantly downregulated in osteosarcoma tissues and cell lines.
  • Epigenetic alterations, including increased repressive marks (H3K9me3, H3K27me3) and decreased active marks (H3K4me3), were observed on the miR-422a promoter.
  • Overexpression of miR-422a inhibited osteosarcoma cell growth, induced apoptosis, and caused cell cycle arrest both in vitro and in vivo.
  • miR-422a directly targets BCL2L2 and KRAS, negatively regulating their protein expression.

Conclusions:

  • miR-422a functions as a tumor suppressor in osteosarcoma by inhibiting BCL2L2 and KRAS.
  • Restoration of miR-422a exhibits anti-tumor effects and could be a novel therapeutic strategy for osteosarcoma.
Keywords:
BCL2L2KRASmiR-422aosteosarcoma

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K